AXIN2 and colorectal carcinoma: Further investigation revealed that Isopenicins A is capable of reducing the levels of activated β-catenin and expression of WNT target genes, such as Axin 2, c-Myc, and Survivin, thereby inhibiting the growth of CRC cells [166].